Aquestive Therapeutics, Inc. (NASDAQ:AQST) Chief Development Officer Matthew W. Davis filed a Form 4 on November 12, 2026, disclosing a disposition of 5,303 shares of common stock on November 10, 2026, related to RSU vesting.
Key Highlights
- Reporting person: Matthew W. Davis, Chief Development Officer of Aquestive Therapeutics, Inc.
- Transaction date: November 10, 2026
- Shares disposed: 5,303 shares of common stock, transaction code F (shares withheld for tax)
- Price per share: $3.52
- Remaining beneficial ownership: 94,697 shares of common stock, held directly
- Purpose: Shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units (RSUs)
Davis RSU Tax Withholding Transaction at Aquestive Therapeutics
According to the filing, Matthew W. Davis, serving as Chief Development Officer of Aquestive Therapeutics, Inc., reported a single non-derivative transaction on November 10, 2026. The transaction carried code "F," which the filing identifies as shares withheld by the issuer to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units previously granted to him.
The filing reports that 5,303 shares of common stock were disposed of at a price of $3.52 per share. This disposition was direct in nature and was not a discretionary open-market sale. Following the reported transaction, Davis beneficially owned 94,697 shares of common stock directly, according to the filing. No derivative securities transactions were reported in Table II of the form.
The Form 4 was signed by Thomas Zalewski as Attorney-in-Fact and dated November 12, 2026. The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as the relevant checkbox was not checked.
What Was Disclosed
The filing disclosed that Aquestive Therapeutics Chief Development Officer Matthew W. Davis had 5,303 shares withheld at $3.52 per share on November 10, 2026, to cover RSU-related tax obligations, leaving him with direct beneficial ownership of 94,697 shares.



Please wait processing your request...